Aldara (imiquimod) cream for refractory common and plantar warts

February 2000

Some dermatologists are now prescribing Aldara (imiquimod) cream for refractory common and plantar warts. ...

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Practice chart of the significant new drugs approved in 1999
More info is becoming available on herbals, etc
Cardiology whether it's safe to combine a statin and gemfibrozil (Lopid)
Cardiology using niacin to lower cholesterol might actually INCREASE the risk of heart disease
Dermatology Aldara (imiquimod) cream for refractory common and plantar warts
Dermatology Rogaine (minoxidil 2%) will now be available without a prescription
Diabetes alcohol can affect the risk of developing type 2 DIABETES
Diabetes Many patients aren't using their insulin pens correctly
Hematology Oncology Effexor or Prozac can reduce hot flashes in some cancer survivors
Hematology Oncology Internet rumor that antiperspirants cause breast cancer
Alpha lipoic acid is now showing up in all kinds of "diabetes supplements"
Infectious Diseases new 2-dose regimen for the hepatitis B vaccine, Recombivax HB (Merck Frosst)
Infectious Diseases changes in the recommended dosing for the Lyme vaccine (Lymerix)
Alzheimer s Disease possible interaction between Aricept (donepezil) and Paxil (paroxetine)
Alzheimer s Disease high cholesterol might increase the risk of Alzheimer's
Gastroenterology Important new warnings about Prepulsid (cisapride) are coming out
Gastroenterology Celebrex (celecoxib) is now approved in the U.S. for a hereditary form of colorectal cancer
Osteoporosis various isoflavone supplements to prevent or treat osteoporosis
Practice Serevent (salmeterol) is now approved for asthma in children as young as 4